Pradžia › Rabdomiosarkoma › Masčusetsas
Rabdomiosarkoma klinikiniai tyrimai Masčusetsas
4 tyrimai dėl Rabdomiosarkoma ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Dana-Farber Cancer Institute, Boston
- UMass Memorial Medical Center - University Campus, Worcester
Renkami dalyviai3 fazė
Iki 50 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT07466316PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Renkami dalyviai1/2 fazė
Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-07-22 · NCT06721689VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Boston Children's Hospital, Boston
Renkami dalyviai1/2 fazė
6 Months – 30 Years · Visoms lytims · Atnaujinta 2026-06-02 · NCT04796012Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 49 · Visoms lytims · Atnaujinta 2026-02-19 · NCT06709495Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.